Analys

Evaxion: Fast Track Designation from the FDA - Redeye

{newsItem.title}

Redeye Publicerad: 21 Jan 2023 00:14

Redeye sees the FDA's fast track designation for EVX-01 as a validation of the personalised vaccin approach. It also confers certain regulatory benefits.

Länk till analysen i sin helhet: https://www.redeye.se/research/871551/evaxion-fast-track-designation-from-the-fda?utm_source=finwire&utm_medium=RSS

Nyheter om Fast Track

Läses av andra just nu

Om aktien Fast Track

Senaste nytt